Therapeutic Silencing of Centromere Protein X Ameliorates Hyperglycemia in Zebrafish and Mouse Models of Type 2 Diabetes Mellitus

@article{Zang2019TherapeuticSO,
  title={Therapeutic Silencing of Centromere Protein X Ameliorates Hyperglycemia in Zebrafish and Mouse Models of Type 2 Diabetes Mellitus},
  author={Liqing Zang and Yasuhito Shimada and Hiroko Nakayama and Wenbiao Chen and Ayaka Okamoto and Hiroyuki Koide and Naoto Oku and Takehisa Dewa and Masayuki Shiota and Norihiro Nishimura},
  journal={Frontiers in Genetics},
  year={2019},
  volume={10}
}
Type 2 diabetes mellitus (T2DM) is characterized by persistent hyperglycemia and is influenced by genetic and environmental factors. Optimum T2DM management involves early diagnosis and effective glucose-lowering therapies. Further research is warranted to improve our understanding of T2DM pathophysiology and reveal potential roles of genetic predisposition. We have previously developed an obesity-induced diabetic zebrafish model that shares common pathological pathways with humans and may be… 

Figures and Tables from this paper

The Protective Roles and Molecular Mechanisms of Troxerutin (Vitamin P4) for the Treatment of Chronic Diseases: A Mechanistic Review
TLDR
Evidence is presented from the diversity of in vitro and in vivo studies on the therapeutic potential of TRX against neurodegenerative, diabetes, cancer and cardiovascular diseases with the purpose to find molecular pathways related to the treatment efficacy.
Evaluation of the Percutaneous Absorption of Drug Molecules in Zebrafish
TLDR
The findings suggest that zebrafish are capable of absorbing drug molecules through their skin, but the present data cannot demonstrate thatZebrafish is a practical model to predict human skin absorption.
Potential for Genetic Improvement of Resistance to Perkinsus olseni in the Manila Clam, Ruditapes philippinarum, Using DNA Parentage Assignment and Mass Spawning
TLDR
The preliminary results provided by this study show high potential for selecting clams resistant to parasite load and a limited genetic correlation between resistance and growth, which suggests that breeding programs could incorporate dual selection without negative interactions.
Ambulatory glucose profile in managing post-prandial hyperglycaemia in patients with type 2 diabetes mellitus: a case report
TLDR
This case study indicates that CGM can help improve the understanding of glycemic patterns and can have a beneficial effect on glycemic control.
Review: Zebrafish (Danio Rerio) Sebagai Model Obesitas dan Diabetes Melitus Tipe 2
Zebrafish (Danio rerio) yang sebelumnya disebut Brachydanio rerio merupakan spesies ikan air tawar tropis yang berukuran kecil yang berasal dari Asia Selatan dan Sungai Gangga di India. Zebrafish
Gut-Based Strategies to Reduce Postprandial Glycaemia in Type 2 Diabetes
TLDR
The various strategies that have been proposed to modulate gastrointestinal function, particularly by slowing gastric emptying and/or stimulating incretin hormone GLP-1, are summarized in this review.

References

SHOWING 1-10 OF 70 REFERENCES
Development of a Novel Zebrafish Model for Type 2 Diabetes Mellitus
TLDR
A zebrafish model of T2DM that shows promise as a platform for mechanistic and therapeutic studies of diet-induced glucose intolerance and insulin resistance is developed and the gene expression profiling of liver-pancreas revealed pathways common to human T2 DM.
Zebrafish as a Model for Obesity and Diabetes
TLDR
Zebrafish is an attractive model system for studying metabolic diseases because of the functional conservation in lipid metabolism, adipose biology, pancreas structure, and glucose homeostasis and is also suited for identification of novel targets associated with the risk and treatment of obesity and diabetes in humans.
Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity
TLDR
A zebrafish model of diet-induced obesity (DIO) that shared common pathophysiological pathways with mammalian obesity is established and can be used to identify putative pharmacological targets and to test novel drugs for the treatment of human obesity.
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
TLDR
It is reported that S6K1-deficient mice are protected against obesity owing to enhanced β-oxidation, however on a high fat diet, levels of glucose and free fatty acids still rise in S6k1- deficient mice, resulting in insulin receptor desensitization.
Skeletal muscle insulin resistance in zebrafish induces alterations in β-cell number and glucose tolerance in an age- and diet-dependent manner.
TLDR
The relatively slow progression from insulin resistance to glucose intolerance in this model system has the potential in the future to test cooperating genes or metabolic conditions that may accelerate the development of diabetes and provide new therapeutic targets.
Loss of mTORC1 signalling impairs β-cell homeostasis and insulin processing
TLDR
It is shown that β-cell-specific loss of mTORC1 causes diabetes and β- cell failure due to defects in proliferation, autophagy, apoptosis and insulin secretion by using mice with conditional (βraKO) and inducible (MIP-βraKOf/f) raptor deletion.
Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis
TLDR
Dietary eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis and increases mitochondrial size and mtDNA content, which resulted in ATP production in HepG2 cells and zebrafish.
High-throughput gene targeting and phenotyping in zebrafish using CRISPR/Cas9.
TLDR
A cloning-free single-guide RNA (sgRNA) synthesis, coupled with streamlined mutant identification methods utilizing fluorescent PCR and multiplexed, high-throughput sequencing is described, which shows that efficiency of CRISPR/Cas9 is sixfold more efficient than other techniques.
...
...